Westpac Banking Corp’s Charles River Laboratories CRL Stock Holding History

Westpac Banking Corp’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-588	Closed	-$101K	–	507
2026 Q1	$101K	Sell	588 -364	-38%	-$67.5K	0.01%	424
2025 Q4	$190K	Sell	952 -7	-0.7%	-$1.27K	0.01%	361
2025 Q3	$150K	Sell	959 -35	-4%	-$5.56K	0.01%	377
2025 Q2	$151K	Sell	994 -44	-4%	-$5.87K	0.01%	379
2025 Q1	$156K	Sell	1,038 -34	-3%	-$5.7K	0.01%	359
2024 Q4	$198K	Sell	1,072 -44	-4%	-$8.48K	0.01%	370
2024 Q3	$220K	Buy	+1,116	New	+$232K	0.01%	363
2023 Q2	–	Sell	-4,303	Closed	-$868K	–	562
2023 Q1	$868K	Hold	4,303	–	–	0.01%	676
2022 Q4	$938K	Hold	4,303	–	–	0.01%	623
2022 Q3	$847K	Hold	4,303	–	–	0.01%	650
2022 Q2	$921K	Hold	4,303	–	–	0.01%	680
2022 Q1	$1.22M	Hold	4,303	–	–	0.01%	660
2021 Q4	$1.62M	Hold	4,303	–	–	0.02%	613
2021 Q3	$1.78M	Hold	4,303	–	–	0.02%	608
2021 Q2	$1.59M	Buy	+4,303	New	+$1.44M	0.02%	656

Other funds holding CRL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Westpac Banking Corp's CRL Position: Q2 2026 in Review

Westpac Banking Corp sold out of Charles River Laboratories (CRL) in Q2 2026, closing a stake of 588 shares — an estimated $101K sold.

Westpac Banking Corp first reported a position in CRL in Q2 2021 and held it in 15 quarters. The position peaked at $1.78M in Q3 2021. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

Westpac Banking Corp reported no remaining Charles River Laboratories position as of Q2 2026 after selling out during the quarter.
Westpac Banking Corp sold 588 Charles River Laboratories shares in Q2 2026, an estimated $101K.
Westpac Banking Corp first reported a position in Charles River Laboratories in Q2 2021 and held it in 15 quarters.
Westpac Banking Corp's Charles River Laboratories position peaked at $1.78M in Q3 2021.
570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Westpac Banking Corp's 13F filing for Q2 2026, filed 12 Aug 2026.